Treat to target with ustekinumab for Crohn's disease. Ungaro RC, Colombel JF. Lancet Gastroenterol Hepatol 2022;7:276-277.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ungaro RC, Colombel JF. Treat to target with ustekinumab for Crohn's disease. Lancet Gastroenterol Hepatol 2022;7:276-277.
PMID: 35120657